Bombay High Court Rules Mere Storage of Medicines in Refrigerator Does Not Constitute Manufacturing Process

Introduction

In a significant ruling for labor and social security law, the Bombay High Court has held that the act of a trader storing medicines in a refrigerator does not qualify as a "manufacturing process" under Section 2(k) of the Factories Act, 1948. This decision exempts such premises from being classified as a "factory" under the Employees' State Insurance Act, 1948 (ESI Act), thereby relieving the establishment from mandatory ESI contributions. Delivered by single-judge Justice Jitendra Jain on February 2, 2026, in the case of Madhu Malti Enterprises vs. The Employees State Insurance Corporation (First Appeal No. 291 of 2016), the judgment overturns a lower court's order that had imposed a contribution demand of Rs 68,016 on the appellant. The ruling clarifies the scope of "manufacturing process" in the context of cold storage provisions, distinguishing between industrial cold storage facilities and ordinary refrigerators, and emphasizes the need for a preceding "process" before storage. This decision has implications for small-scale pharmaceutical traders and similar businesses, potentially reducing their compliance burden under welfare legislation while underscoring the precise interpretation required for statutory definitions.

The case arose from an inspection of the appellant's shop in Mumbai's Mazgaon area, where 10 employees were found working, leading the ESI Corporation to deem the premises a factory due to the storage of medicines in cold conditions. Justice Jain's detailed analysis rejects this interpretation, highlighting that the appellant's role is purely that of a trader—purchasing, storing briefly, and selling medicines—without any transformative activity. This judgment, cited as, reinforces the boundaries of social security obligations for non-manufacturing entities and may influence how enforcement authorities apply the ESI Act to retail and distribution setups.

Case Background

Madhu Malti Enterprises, the appellant, operates as a wholesale distributor of medicines from Unit No. 19, 3rd Floor, Thakkar Industrial Estate, C.B. Road, Mazgaon, Mumbai. Registered under the Bombay Shops and Establishments Act, the business involves procuring medicines from pharmaceutical companies, storing them in a 365-liter refrigerator to maintain efficacy, and selling them to druggists and chemists. On April 20, 2006, ESI Corporation officials conducted a surprise inspection at the premises, observing around 10 persons employed there. Despite the shop's registration as an establishment rather than a factory, the Corporation issued a show-cause notice on September 20, 2006, followed by an ESI Code assignment on May 9, 2007.

The ESI Corporation demanded Rs 68,016 as contributions under the ESI Act, arguing that the premises qualified as a "factory" because more than 10 persons were employed and the storage of medicines in a refrigerator constituted a "manufacturing process" under Section 2(k)(vi) of the Factories Act—specifically, "preserving or storing any article in cold storage." Aggrieved by this, Madhu Malti Enterprises challenged the demand before the ESI Court in 2009. On June 29, 2011, the recovery proceedings were stayed, but on September 8, 2015, the ESI Court ruled against the appellant in a detailed judgment, upholding the Corporation's view that the preservation activity extended the manufacturing process from the pharmaceutical production stage. This prompted the filing of First Appeal No. 291 of 2016 before the Bombay High Court, admitted on August 19, 2019, on the substantial question of law: whether using a refrigerator for medicine storage amounts to a continuation of the manufacturing process.

The timeline underscores the protracted nature of such disputes, spanning nearly two decades from the initial inspection to the High Court's resolution. The core legal questions centered on the interpretation of "manufacturing process" under the linked provisions of the ESI Act (Sections 2(12) and 2(14-AA)) and the Factories Act, particularly whether incidental storage by a trader triggers factory status and ESI applicability. No disputes arose regarding the number of employees, focusing the appeal squarely on the definitional threshold for manufacturing.

Arguments Presented

The appellant, represented by Advocates V.P. Vaidya and Mahendra Agavekar, contended that Madhu Malti Enterprises is merely a trader engaged in distribution, not manufacturing. They argued that storing medicines in a refrigerator is an incidental activity to preserve product integrity for resale, not a continuation or extension of any manufacturing process. Emphasizing the business's registration under the Shops and Establishments Act, they asserted that the ESI Act's applicability requires the premises to be a "factory" involving a genuine manufacturing process, which involves transformation or adaptation of goods. The appellants relied on precedents such as Ritz Hotel (Vegetarian) Pune v. Joint Regional Director (1994 Supreme (Bom) 411), where hotel operations were not deemed manufacturing; Regional Director, ESI Corporation v. Serofie Bernard Vaz (2009 (1) LLN 496), distinguishing preservation from production; Hotel New Nalanda v. Regional Director, ESI Corporation (2009-IV-LLJ-21 (SC)), excluding service-oriented establishments; and The Management of Kumar Medical Centre v. Employees State Insurance Corporation (2011 (2) CWC 802), a directly analogous case involving pharmaceutical wholesale where storage was ruled non-manufacturing. They stressed that no activity precedes the storage—medicines arrive pre-manufactured—and thus, it falls outside Section 2(k)(vi)'s purview. Factual points included the use of a standard 365-liter domestic refrigerator, not an industrial cold storage, and the absence of any processing like packing or treating the medicines.

In opposition, Advocate Shailesh Pathak for the ESI Corporation argued for a broad interpretation favoring welfare objectives. They submitted that Sections 2-A, 2(12), and 2(14-AA) of the ESI Act, read with Section 2(k)(vi) of the Factories Act, encompass the preservation of medicines in cold conditions as integral to the manufacturing chain, continuing until disposal. The respondents contended that "manufacturing process" need not create a new product but can include maintenance or preservation, especially under beneficial legislation like the ESI Act, where ambiguities should resolve in favor of employee coverage. They highlighted the employment of 10 persons and the cold storage's role in preventing spoilage, equating the refrigerator's function to cold storage under the statute. Citing Vellipalayam Co-operative Milk Supply Society v. Regional Director, ESI Corporation and Kumbakonam Milk Supply Co-operative Society v. Regional Director, ESI Corporation (Madras High Court decisions), they argued that storing perishables like medicines inherently involves a process for preservation, making the premises a factory liable for contributions. The Corporation dismissed the refrigerator-cold storage distinction as semantic, urging application of the Act's social welfare intent to protect workers' physical well-being.

Both sides presented detailed factual contrasts: the appellant as a non-transformative trader versus the respondents' view of integrated preservation in trade. Legal points pivoted on statutory language—"process for" versus mere "act of"—and the Act's scheme to cover hazardous or process-oriented environments.

Legal Analysis

Justice Jitendra Jain's reasoning meticulously dissects the statutory framework, rejecting the ESI Court's extension of manufacturing to include mere preservation. Central to the analysis is Section 2(k)(vi) of the Factories Act, defining "manufacturing process" as "any process for preserving or storing any article in cold storage." The court parsed the phrase "process for," holding that it implies a condition precedent: some activity must precede or accompany the storage to qualify. Mere storage by a trader, without prior treatment or adaptation, does not suffice. As Justice Jain observed, if the legislature intended standalone preservation, it would have used "process of" rather than "for," creating a purposeful distinction.

The judgment draws on the undefined term "process" in both Acts, interpreting it as requiring "some continuous and regular action" on the product, akin to transformation in manufacturing. Referencing settled law that processing is a subset of manufacturing but not all processes constitute it, the court noted that a new product need not emerge, but an active intervention is essential. In this case, the appellant performs no such activity—medicines are bought ready-made, refrigerated briefly, and sold unchanged. This aligns with Delhi Cold Storage Pvt. Ltd. v. Commissioner of Income Tax ((1991) 4 SCC 239), where the Supreme Court held that refrigeration-induced changes (e.g., moisture loss) do not amount to a "process" without intentional activity, emphasizing no transformation occurs here.

Justice Jain explicitly distinguished cold storage from a refrigerator, a point reinforced by precedents like Unity Traders v. The Regional Director, ESI Corporation , Mohd. Arif v. Employees State Insurance Corporation , Employees State Insurance Corporation v. Sumangalam Restaurant , and The Management of Kumar Medical Centre v. Employees State Insurance Corporation . Cold storage denotes large-scale, scientifically controlled facilities for bulk perishables, whereas a 365-liter refrigerator is a domestic appliance unsuitable for the statutory intent. The court clarified that the ruling is fact-specific, not barring all cold storage from manufacturing classification.

Addressing the ESI Act's welfare nature, Justice Jain affirmed its beneficial scope but insisted eligibility tests must be met strictly—coverage cannot expand via loose interpretation without statutory fit. The Act targets establishments affecting workers' physical well-being through manufacturing, but trading with incidental storage does not qualify. Precedents favoring the respondents, like the Madras High Court milk society cases, were distinguished for failing to analyze "process for" and assuming post-amendment applicability without relevance here. The appellant's cited cases supported exemption for non-manufacturing trades, though the court developed an independent view.

This analysis delineates key concepts: manufacturing requires proactive processes, not passive storage; welfare laws demand precision to avoid overreach. For pharmaceutical distributors, it clarifies that brief refrigeration in retail settings does not invoke factory status, potentially shielding similar small enterprises from ESI scrutiny unless active processing occurs.

Key Observations

The judgment features several pivotal excerpts underscoring the court's interpretive rigor:

• "Definition of 'manufacturing process' means any process for preserving or storing any article in cold storage. In my view, the mere act of preserving or storing any article in cold storage would not amount to manufacturing process. The act of preserving or storing any articles in cold storage is preceded by 'process for' preserving or storing any articles in cold storage. It is the process for preserving or storing which amounts to manufacturing process and not the mere act of preserving or storing."

• "The word 'process' is not defined by the Factories Act or by the ESI Act but the word 'process' would mean some activity should be carried out on the product and that activity should be for preserving or storing any article in cold storage. Mere preserving or storing any article in cold storage would not amount to manufacturing process because it is not preceded in the instant case by any process."

• "There is a difference between a cold storage and a refrigerator. Cold storage refers to a large, insulated, mechanically cooled facility meant for storing large quantities of perishable goods under scientifically controlled conditions for longer duration. Whereas a refrigerator, of 365 liters is a domestic appliance which is used mainly in residential premises and in offices to keep various items like vegetables, fruits etc. and in the instant case, to keep the medicines."

• "Admittedly in the instant case, the appellant does not carry out any activity of any nature on the medicines which is already manufactured by pharma companies. He merely stores medicines in refrigerator till he sells the same to a Chemist. In my view, merely storing of a medicines by a trader in refrigerator would not make act of storing a 'manufacturing process' as per Section 2(k) of the Factories Act, 1948."

• "It is settled position that in a process, new product may not come into existence but in manufacturing a new product should come into existence. Processing is a part of manufacturing. All processes need not amount to manufacture, but all manufacturing is a result of various processes."

These observations, attributed to Justice Jitendra Jain, encapsulate the nuanced statutory reading that drove the outcome.

Court's Decision

The Bombay High Court allowed the appeal, quashing the ESI Court's September 8, 2015, judgment and setting aside the ESI Corporation's demand for Rs 68,016 in contributions. Justice Jain answered the substantial question of law in the appellant's favor, ruling that the premises do not constitute a "factory" under the ESI Act due to the absence of a "manufacturing process." The operation of the order was stayed for eight weeks to allow the respondents to pursue further remedies.

Practically, this exempts Madhu Malti Enterprises from ESI registration and payments, affirming its status as a shop under the Bombay Shops and Establishments Act. Broader implications include relief for pharmaceutical wholesalers and similar traders using standard refrigerators for perishables, preventing erroneous classifications that could burden small businesses with social security costs. Enforcement authorities must now demonstrate active processes beyond mere storage, potentially reducing frivolous demands and litigation. However, the fact-specific caveat means large-scale cold storage operations remain covered, preserving the Act's intent for industrial settings.

For future cases, the ruling promotes precise application of Section 2(k), influencing ESI audits in trading sectors. It balances welfare goals with statutory fidelity, ensuring coverage targets true manufacturing risks without overextension. Legal professionals advising distributors should note this precedent to challenge similar impositions, fostering clarity in labor law compliance amid evolving business practices.

In the evolving landscape of social security, this decision reinforces that intent alone cannot expand statutory definitions—only fitting activities trigger obligations. As pharmaceutical distribution grows, such interpretations safeguard entrepreneurial activities while upholding worker protections where genuinely warranted.